Based on the important target roles of BRD9 and TAF1(2) in drug design toward human cancers, Crawford and coworkers solved the crystal structures of 67B- and 69G-bound BRD9, as well as 67B- and 67C-associated TAF1(2) [22]. This evidence concerns the gene TAF1 and cancer.